Latest Breaking News On - பள்ளி ஆஃப் புற்றுநோய் - Page 1 : comparemela.com
Guy s and St Thomas Trust to use AI tool in cancer trials
ukauthority.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ukauthority.com Daily Mail and Mail on Sunday newspapers.
Inspirata, Inc : Inspirata Partners with King s Health Partners ECMC and Guy s and St Thomas NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Inspirata Partners with King s Health Partners ECMC and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Inspirata Partners with King s Health Partners ECMC and Guy s and St Thomas NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Cancer patients less protected after first COVID vaccine jab, UK study finds
Cancer patients are much less protected against Covid-19 than other people after one dose of the Pfizer vaccine, the first real-world study in this area suggests.
Share Via Email
| A+A A- By PTI
LONDON: Cancer patients may not be protected to the same degree as the rest of the population after they receive their first of two doses of a COVID-19 vaccine, a new UK study has found on Thursday.
A team of experts from King s College London and Francis Crick Institute found in the first real-world study of its kind that a shorter than the stipulated 12-week gap between the two vaccine doses for such patients appeared to be the answer.